Create a narrative

ARS Pharmaceuticals Community

NasdaqGM:SPRY Community

1 Narratives written by author
0 Comments on narratives written by author
22 Fair Values set on narratives written by author

Create a narrative

ARS Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

80% Coverage And Pediatric Launch Will Expand Global Markets

Key Takeaways Rapid payer coverage expansion and pediatric market entry may enhance revenue and ease prescribing burdens with reduced authorization requirements. International expansion and targeted advertising campaigns could drive brand awareness, new revenue streams, and higher prescription volumes.

US$31.60

FV

54.2% undervalued

97.60%

Revenue growth p.a.

0

0

0

2 days ago